Clinical Trials · NCT00624481

Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMD

Name: Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMD
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

WithdrawnPhase 2Teriparatide

Phase: Phase 2
Recruitment status: Withdrawn
Sponsor: Nastech Pharmaceutical Company, Inc.
Enrollment: 350
Start date: Mar 2008
Locations: See registry
Primary endpoint: Change in bone mineral density of the lumbar spine from baseline to 24 weeks post treatment.

View Teriparatide compound reference